Systemic lupus erythematosus in Asturias, Spain: Clinical and serologic features

Medicine

Volumn 85, Issue 3, 2006, Pages 157-168

  Gómez, Jesús ^a   Suárez, Ana ^b   López, Patricia ^b   Mozo, Lourdes ^a   Díaz, José Bernardino ^a   Gutiérrez, Carmen ^a,b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; DNA ANTIBODY; LA ANTIBODY; LUPUS ANTICOAGULANT; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SM ANTIBODY;

ADOLESCENT; ADULT; ALOPECIA; BLOOD SAMPLING; CLINICAL FEATURE; DATA BASE; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; KIDNEY DISEASE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; NEUROPATHY; ONSET AGE; PRIORITY JOURNAL; RASH; REVIEW; SPAIN; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; ANTIBODIES, ANTINUCLEAR; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHATIC DISEASES; MALE; MIDDLE AGED; PROGNOSIS; RIBONUCLEOPROTEINS; SEROEPIDEMIOLOGIC STUDIES; SEROSITIS; SEX FACTORS; SPAIN; SURVIVAL ANALYSIS;

EID: 33744787610     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000224711.54886.b1     Document Type: Review

References (53)

1. Abusamieh M, Ash J. Atherosclerosis and systemic lupus erythematosus. Cardiol Rev. 2004;12:267-275.
2. Beaufils M, Kouki F, Mignon F, Camus JP, Morel-Maroger L, Richet G. Clinical significance of anti-Sm antibodies in systemic lupus erythematosus. Am J Med. 1983;74:201-205.
3. Boddaert J, Huong du LT, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore). 2004;83:348-359.
4. Borchers AT, Keen CL, Schoenfeld Y, Gershwin ME. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. Autoimmun Rev. 2004;3:423-453.
5. Brey RL, Stallworth CL, McGlasson DL, Wozniak MA, Wityk RJ, Stern BJ, Sloan MA, Sherwin R, Price TR, Macko RF, Johnson CJ, Earley CJ, Buchholz DW, Hebel JR, Kittner SJ. Antiphospholipid antibodies and stroke in young women. Stroke. 2002;33:2396-2400.
6. Camilleri F, Mallia C. Male SLE patients in Malta. Adv Exp Med Biol. 1999;455:173-179.
7. Carreno L, Lopez-Longo FJ, Monteagudo I, Rodriguez-Mahou M, Bascones M, Gonzalez CM, Saint-Cyr C, Lapointe N. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus. 1999;8:287-292.
8. Catoggio LJ, Skinner RP, Smith G, Maddison PJ. Systemic lupus erythematosus in the elderly: Clinical and serological characteristics. J Rheumatol. 1984;11:175-181.
9. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Domenech I, Aydintug AO, Jedryka-Goral A, de Ramon E, Galeazzi M, Haga HJ, Mathieu A, Houssiau F, Ingelmo M, Hughes GRV; European Working Party on Systemic Lupus Erythematosus. Systemic lupus erythematosus: clinical and immunological patterns of disease expression in a cohort of 1,000 patients. Medicine (Baltimore). 1993;72:13-124.
10. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC, Aydintug AO, Chwalinska-Sadowska H, de Ramon E, Fernandez-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR; European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003;82:299-308.
11. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum. 1998;41:1714-1724.
12. Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Cohen PL, Roubey RAS, Dooley MA. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus. 2002;11:161-167.
13. Deligny C. Thomas L, Dubreuil F, Theodose C, Garsaud AM, Numeric P, Ranlin A, Jean-Baptiste G, Arfi S. Systemic lupus erythematosus in Martinique: an epidemiologic study. Rev Med Interne. 2002;23:21-29.
14. Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. SSC subcommittee for the standardization of lupus anticoagulants. Thromb Haemost. 1991;65:320-322.
15. Faller G, Thomson PD, Kala UK, Hahn D. Demographics and presenting clinical features of childhood systemic lupus erythematosus. S Afr Med J. 2005;95:424-427.
16. Font J, Cervera R, Espinosa G, Pallares L, Ramos-Casals M, Jimenez S, Garcia-Carrasco M, Seisdedos L, Ingelmo M. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis. 1998;57:456-459.
17. Gomez-Gomez P. Bases bioantropologicas de Asturias. In: Rodriguez-Munoz J, ed. Los Asturianos. Raices Culturales y Sociales de Una Identidad. Oviedo: Editorial Prensa Asturiana/La Nueva Espana; 2005:72.
18. Gourley IS, Patterson CC, Bell AL. The prevalence of systemic lupus erythematosus in Northern Ireland. Lupus. 1997;6:399-403.
19. Gudmundsson S, Steinsson K. Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population. J Rheumatol. 1990;17:1162-1167.
20. Hopkinson ND, Doherty M, Powell RJ. The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br J Rheumatol. 1993;32:110-115.
21. INEbase. Spain: Instituto Nacional de Estadistica; 2004. Available at: http://www.ine.es/inebase. Accessed November 15, 2005.
22. Isenberg DA, Garton M, Reichlin MW, Reichlin M. Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients. Br J Rheumatol. 1997;36:229-233.
23. Jimenez S, Cervera R, Font J, Ingelmo M. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2003;25:3-12.
24. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum. 1995;38:551-558.
25. Koskenmies S, Widen E, Kere J, Julkunen H. Familial systemic lupus erythematosus in Finland. J Rheumatol. 2001;28:758-760.
26. Lopez-Longo FJ, Gonzalez-Fernandez CM, Rodriguez-Mahou M, Gau-Simo R, Monteagudo-Saez I, Meno-Garcia AC, Carreno-Perez L. Clinical expresion of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies. Rev Clin Esp. 1997;197:329-335.
27. Lopez P, Mozo L, Gutierrez C, Suarez A. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus. 2003;12:860-865.
28. Maddinson PJ. Systemic lupus erythematosus in the elderly. J Rheumatol. 1987;14(Suppl 13):182-187.
29. Manzi S. Epidemiology of systemic lupus erythematosus. Am J Manag Care. 2001;7(Suppl 16):S474-479.
30. Miller MH, Urowitz MB, Gladman DD, Killinger DW. Systemic lupus erythematosus in males. Medicine (Baltimore). 1983;62:327-334.
31. Nossent HC. Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol. 2001;28:539-546.
32. Phan JC, Bush TM, Donald F, Ward M. Clinical and laboratory features of patients of Vietnamese descent with systemic lupus erythematosus. Lupus. 1999;8:521-524.
33. Peschken CA, Esdaile JM. Systemic lupus erythematosus in North American Indians: a population based study. J Rheumatol. 2000;27:1884-1891.
34. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Clin Rheumatol. 2002;16:847-858.
35. Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, Abadi I, Caeiro F, Alvarellos A, Alarcon-Segovia D, on behalf of the Grupo Latinoamericano de Estudio del Lupus (GLADEL). The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus. Ethnic and disease heterogeneity among "Hispanics". Medicine (Baltimore). 2004;83:1-17.
36. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 1990;33:37-48.
37. Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol. 2003;30:985-992.
38. Segasothy M, Phillips PA. Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study. Lupus. 2001;10:439-444.
39. Sekigawa I, Naito T, Hira K, Mitsuishi K, Ogasawara H, Hashimoto H, Ogawa H. Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus. 2004;13:217-222.
40. Shivastava A, Dwivedi S, Aggarwal A, Misra R. Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures. Lupus. 2001;10:45-50.
41. Soto ME, Vallejo M, Guillen F, Simon JA, Arena E, Reyes PA. Gender impact in systemic lupus erythematosus. Clin Exp Rheumatol. 2004;22:713-721.
42. Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol. 2000;27:685-691.
43. Sthoeger ZM, Geltner D, Rider A, Bentwich Z. Systemic lupus erythematosus in 49 Israeli males: a retrospective study. Clin Exp Rheumatol. 1987;5:233-240.
44. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277.
45. Teh LS, Lee MK, Wang F, Manivasagar M, Charles PJ, Nicholson GD, Hay EM, Isenberg DA, Amos N, Williams BD. Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus. Br J Rheumatol. 1993;32:663-665.
46. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976;60:221-225.
47. Vasoo S, Hughes GRV. Perspectives on the changing face of lupus mortality. Autoimmun Rev. 2004;3:415-417.
48. Vilar MJP, Sato EI. Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). Lupus. 2002;23:21-29.
49. Voss AB, Green A, Junker P. Systemic lupus erythematosus in the county of Fynen. An epidemiological study. Ugeskr Laeger. 1999;161:3837-3840.
50. Voulgari PV, Katsimbri P, Alamanos Y, Drosos AA. Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature. Lupus. 2002;11:722-729.
51. Wang J, Satoh M, Kabir F, Shaw M, Domingo MA, Mansoor R, Behney KM, Dong X, Lahita RG, Richards HB, Reeves WH. Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum. 2001;44:2367-70.
52. Yacoub Wasef SZ. Gender differences in systemic lupus erythematosus. Gend Med. 2004;1:12-17.
53. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases. A meta-analysis. Arch Intern Med. 2005;165:2337-2344.